Skip to main content
. 2021 Jun 7;11(6):1048. doi: 10.3390/diagnostics11061048

Figure 7.

Figure 7

Marker combinations using ART discriminate between benign and malignant disease. Receiver operator curves (ROC) were used to evaluate the discriminatory power of ART alone compared with (A) individual measurements of total or active CXCL10; or (B) CA125 alone, DPP4 alone or a combination of CA125, DPP4 and ART in ascites samples.